by Johan Van Weyenbergh | Nov 13, 2023 | News
HTLV petition | Maertens Lab
by HTLV | Sep 24, 2023 | News
People living with HTLV-1 in Brazil shared their lived experiences on mother-to-child transmission and policies to prevent transmission. The letter was published at the Lancet Global Health. Portuguese version is available as supplementary data. Women living...
by HTLV | Jul 17, 2023 | News
The Pan American Health Organization/World Health Organization (PAHO/WHO) recognises the importance of Human T cell lymphotropic virus and its detrimental impact in patient`s health. In line with the inclusion of HTLV-1 in the WHO`s Global health sector strategies...
by HTLV | Jul 16, 2023 | News
The IRVA community, and the viral oncology research field in general, lost one of its precious contributors when Luigi Chieco-Bianchi died unexpectedly on June 23, 2023. We express our deepest sympathy to Luigi’s wife Anna Maria, their daughters Fulvia, Maria...
by Johan Van Weyenbergh | Apr 14, 2023 | News
Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model Accompanying Commentary: Recommendations against breastfeeding require consultation with women for effective implementation
by HTLV | Jan 24, 2023 | News
We are calling for Expressions of interest to join 2 IRVA working parties and encouraging representation from each country. There are 2 proposed working groups to be established: Testing Working GroupSurveillance Working Group The HTLV Surveillance Working Group will...
